ST Elevation Myocardial Infarction Clinical Trial
— DANAMI4Official title:
The STEMI Optimization Trial - Ischemic Postconditioning (DANAMI4-iPOST) and Intravascular Ultrasound Guided PCI in STEMI (DANAMI4-iSTEMI)
The purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.
Status | Recruiting |
Enrollment | 2500 |
Est. completion date | February 1, 2031 |
Est. primary completion date | February 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age =18 years - Acute onset of chest pain with <12 hours duration - STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI. Exclusion Criteria (iPOST2): Pre-PCI TIMI flow 0 or 1 Potential pregnancy Inability to provide informed consent Unwillingness to consent Unavoidable to use thrombectomy Spontaneous coronary artery dissection Time from symptoms onset to PPCI > 12 hours Culprit in bypass graft Other reason for not including the patient Exclusion Criteria (iSTEMI): Potential pregnancy Inability to understand information in order to provide informed consent Unwillingness to consent Spontaneous coronary artery dissection Time from symptoms inset to PPCI > 12 hours Culprit in bypass graft Other reason |
Country | Name | City | State |
---|---|---|---|
Denmark | Heart Center, Rigshospitalet | Copenhagen | Capital Region |
Lead Sponsor | Collaborator |
---|---|
Thomas Engstrom |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | iSTEMI (IVUS) | Hospitalization for heart failure | Until expected number of events are adjudicated 3 years | |
Other | iSTEMI (IVUS) | Stroke | Until expected number of events are adjudicated 3 years | |
Other | iSTEMI (IVUS) | Bleeding | Until expected number of events are adjudicated 3 years | |
Other | iSTEMI (IVUS) | Quality of life | 1 year | |
Other | iPOST | Any ischemia driven revascularization | Until expected number of events are adjudicated 3 years | |
Other | iPOST | Bleeding | Until expected number of events are adjudicated 3 years | |
Other | iPOST | Stroke | Until expected number of events are adjudicated 3 years | |
Other | iPOST | Ventricular arrythmia | Until expected number of events are adjudicated 3 years | |
Other | iPOST | ICD | Until expected number of events are adjudicated 3 years | |
Primary | iPOST | Number of participants that experience all-cause mortality or hospitalization for heart failure | Until expected number of events are adjudicated up til 3 years | |
Primary | iSTEMI (IVUS) | Number of participants that experience all-cause mortality, unplanned ischemia-driven revascularization and new myocardial infarction | Until expected number of events are adjudicated up til 3 years | |
Secondary | iSTEMI (IVUS) | Target vessel failure (cardiac mortality, unplanned ischemia driven target vessel revascularization or target vessel myocardial infarction | Until expected number of events are adjudicated 3 years | |
Secondary | iSTEMI (IVUS) | Individual components of the primary endpoint | Until expected number of events are adjudicated 3 years | |
Secondary | iSTEMI (IVUS) | Cardiac mortality | Until expected number of events are adjudicated 3 years | |
Secondary | iSTEMI (IVUS) | Unplanned ischemia driven target vessel revascularization | Until expected number of events are adjudicated 3 years | |
Secondary | iSTEMI (IVUS) | Unplanned ischemia driven target vessel myocardial infarction | Until expected number of events are adjudicated 3 years | |
Secondary | iSTEMI (IVUS) | Unplanned ischemia driven target lesion revascularization | Until expected number of events are adjudicated 3 years | |
Secondary | iSTEMI (IVUS) | Definite/probable stent-thrombosis | Until expected number of events are adjudicated 3 years | |
Secondary | iPOST | Individual components of the primary endpoint | Until expected number of events are adjudicated 3 years | |
Secondary | iPOST | Cardiac mortality | Until expected number of events are adjudicated 3 years | |
Secondary | iPOST | Ischemia driven target vessel revascularization | Until expected number of events are adjudicated 3 years | |
Secondary | iPOST | New myocardial infarction | Until expected number of events are adjudicated 3 years | |
Secondary | iPOST | Quality of life | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05601999 -
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT06147986 -
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
|
Phase 2 | |
Not yet recruiting |
NCT05881382 -
Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
|
Phase 3 | |
Enrolling by invitation |
NCT02615015 -
SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls
|
N/A | |
Recruiting |
NCT05812963 -
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute STEMI
|
N/A | |
Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
Recruiting |
NCT05450757 -
Shanghai ST-segment Elevation Myocardial Infarction Cohort
|
||
Active, not recruiting |
NCT03278509 -
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
|
Phase 4 | |
Not yet recruiting |
NCT03266328 -
Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University
|
N/A | |
Not yet recruiting |
NCT03263468 -
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
|
N/A | |
Completed |
NCT03156699 -
The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction
|
||
Enrolling by invitation |
NCT04970238 -
Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction
|
Phase 4 | |
Recruiting |
NCT02557217 -
NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
|
Phase 2 | |
Recruiting |
NCT02224534 -
Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
|
Phase 4 | |
Completed |
NCT01136187 -
Trial Comparing Radial and Femoral Approach in Primary Percutaneous Coronary Intervention (PCI)
|
N/A | |
Not yet recruiting |
NCT04068116 -
Impact of Ischemic Post-conditioning
|
N/A | |
Not yet recruiting |
NCT04063345 -
Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03646357 -
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
|
Phase 4 | |
Completed |
NCT03984071 -
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
|
||
Completed |
NCT03740776 -
The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI
|